Re-induction of cell differentiation and 131I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection

Nuclear Medicine and Biology

Volumn 39, Issue 8, 2012, Pages 1261-1265

  Feng, Fang ^a   Wang, Hui ^a   Hou, Shasha ^a   Fu, Hongliang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dedifferentiation; Differentiated thyroid carcinoma; Gene transfection; Radioiodine; TSHR

Indexed keywords

IODINE 131; MESSENGER RNA; PLASMID DNA; SODIUM IODIDE SYMPORTER; THYROTROPIN RECEPTOR;

ARTICLE; ASSAY; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOPLASM; DIFFERENTIATED THYROID CANCER; DOWN REGULATION; DRUG MECHANISM; DRUG UPTAKE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC MARKER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IRRADIATION; PROTEIN EXPRESSION; RADIOIODONE UPTAKE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; TSHR GENE; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; IODINE RADIOISOTOPES; ORGAN SPECIFICITY; RECEPTORS, THYROTROPIN; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84867851005     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.07.004     Document Type: Article

References (17)

1. Sacks W., Fung C.H., Chang J.T., Waxman A., Braunstein G.D. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid 2010, 20:1235-1245.
2. Ganti A.K., Cohen E.E. Iodine-refractory thyroid carcinoma. Rev Recent Clin Trials 2006, 1:133-141.
3. Gerard A.C., Daumerie C., Mestdagh C., Gohy S., De Burbure C., Costagliola S., et al. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metab 2003, 88:4977-4983.
4. Feng F., Wang H., Fu H., Wu S., Ye Z., Chen S., et al. Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by (131)I pretreatment. Nucl Med Biol 2011, 38:1053-1058.
5. Smit J.W., Schroder-van der Elst J.P., Karperien M., Que I., Stokkel M., van der Heide D., et al. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line. J Clin Endocrinol Metab 2002, 87:1247-1253.
6. Huang M., Batra R.K., Kogai T., Lin Y.Q., Hershman J.M., Lichtenstein A., et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 2001, 8:612-618.
7. Jeong S.Y., Hwang M.H., Kim J.E., Kang S., Park J.C., Yoo J., et al. Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study. Endocr J 2011, 58:575-583.
8. Ringel M.D. Molecular markers of aggressiveness of thyroid cancer. Curr Opin Endocrinol Diabetes Obes 2009, 16:361-366.
9. Quiros R.M., Ding H.G., Gattuso P., Prinz R.A., Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 2005, 103:2261-2268.
10. Arufe M.C., Lu M., Kubo A., Keller G., Davies T.F., Lin R.Y. Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology 2006, 147:3007-3015.
11. Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol 2007, 17:233-240.
12. Garcia-Jimenez C., Santisteban P. TSH signalling and cancer. Arq Bras Endocrinol Metabol 2007, 51:654-671.
13. Biermann K., Biersack H.J., Sabet A., Janzen V. Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullary thyroid carcinoma. Semin Nucl Med 2011, 41:139-148.
14. Woyach J.A., Shah M.H. New therapeutic advances in the management of progressive thyroid cancer. Endocr Relat Cancer 2009, 16:715-731.
15. Spitzweg C. Gene therapy in thyroid cancer. Horm Metab Res 2009, 41:500-509.
16. Russo D., Damante G., Puxeddu E., Durante C., Filetti S. Epigenetics of thyroid cancer and novel therapeutic targets. J Mol Endocrinol 2011, 46:73-81.
17. Davies T.F., Yin X., Latif R. The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid 2010, 20:727-736.